Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Vaccination rates against human papillomavirus (HPV) among US teens remain stubbornly lower than those of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine and quadrivalent meningococcal conjugate vaccine (MenACWY), according to a recent CDC report.
Data from a 2015 national survey involving more than 22 000 teens aged 13 to 17 years showed that overall, coverage with at least 1 dose of HPV vaccine was 56.1% and 45.4% with 2 or more doses; coverage with the full 3-dose series was 34.9%. In comparison, coverage with 1 or more doses of Tdap was 86.4%, and coverage was 81.3% with at least 1 dose of MenACWY. All 3 vaccines are routinely recommended at age 11 to 12 years.
HPV Vaccination Rates Lag in Teens. JAMA. 2016;316(14):1440. doi:10.1001/jama.2016.14253